N.B. reports two new COVID-19 cases Thursday; active infections drop to 40
Health officials in New Brunswick are reporting two new cases of COVID-19 on Thursday.
One case is in the province's Moncton region (Zone 1) and involves an individual in their 40s. This case remains under investigation, according to public health.
One case is in the Fredericton region (Zone 3) and involves an individual in their 70s. This case is a close contact to a previously reported case.
Five previously reported infections in New Brunswick are now considered recovered, with the total number of active cases dropping to 40 - the lowest number of active cases the province has seen since mid-March.
N.B. COVID-19 CASE DATA
New Brunswick has had 2,322 cumulative cases of COVID-19 since the start of the pandemic.
In total, 2,236 people have recovered, and 45 people have died in the province from COVID-19.
Six people are currently in hospital with COVID-19, including two in an intensive care unit.
In a news release from public health, it says 608 tests were completed on Wednesday in New Brunswick, and 359,298 total since the start of the pandemic.
The number of cases are broken down by New Brunswick’s seven health zones:
- Zone 1 – Moncton region: 475 confirmed cases (1 active case)
- Zone 2 – Saint John region: 298 confirmed cases (3 active cases)
- Zone 3 – Fredericton region: 442 confirmed cases (22 active cases)
- Zone 4 – Edmundston region: 752 confirmed cases (no active cases)
- Zone 5 – Campbellton region: 185 confirmed cases (no active cases)
- Zone 6 – Bathurst region: 131 confirmed cases (14 active cases)
- Zone 7 – Miramichi region: 39 confirmed cases (no active cases)
VACCINE UPDATE
New Brunswick's COVID-19 online dashboard provides an update on the amount of vaccines that have been administered to date.
As of Thursday, 693,708 doses of COVID-19 vaccine have been administered in New Brunswick. The province says 76.7 per cent of the eligible population has received at least one dose, with 23.3 per cent now fully vaccinated.
In a news release from the province on Thursday, it says more than 12,000 second doses of COVID-19 vaccine were administered on Wednesday.
"Over the past seven days, nearly 72,000 first and second doses of a COVID-19 vaccine have been administered across the province, and more than 91,000 people have booked appointments for a Vitalité or Horizon health network clinic," wrote the province in a release.
Public health says those numbers do not include individuals who have booked appointments through a pharmacy.
Eligible New Brunswickers can book a second-dose vaccine appointment if at least 28 days has passed since their first dose.
To receive their second dose, New Brunswickers are asked to bring a signed consent form, their Medicare card and a copy of the record of immunization provided after receiving their first dose.
Appointments for people who have not yet received their first dose continue to be available to all New Brunswickers aged 12 and older at regional health authority clinics and through participating pharmacies.
VACCINE SHIPMENT DELAYED
Health officials in New Brunswick say a Pfizer-BioNTech vaccine shipment that was expected to arrive in the province this week has been delayed, however they added the delay will not impact second dose clinics.
For individuals under the age of 55 who received the AstraZeneca vaccine as their first dose, it is recommended that an mRNA vaccine is scheduled for the second dose, unless informed otherwise.
"If you are 55 or older, you can receive a second dose of AstraZeneca or of an mRNA vaccine," read the release. "People who have received two doses of AstraZeneca can rest assured that the vaccine provides protection against infection, severe disease and hospitalization."
YELLOW LEVEL REMINDER
All of New Brunswick remains under the Yellow level of recovery under the province’s order.
CTVNews.ca Top Stories
NEW From yearning for a change to cost of living, why some Canadians have left or may leave the country
For some immigrants, their dreams of permanently settling in Canada have taken an unexpected twist.
NEW Capital gains tax change 'shortsighted' and 'sows division' business groups tell Freeland
Forging ahead with increasing Canada's capital gains inclusion rate 'sows division,' and is a 'shortsighted' way to improve the deficit, business groups are warning Finance Minister Chrystia Freeland.
Police handcuff man trying to enter Drake's Toronto mansion
Toronto police say a man was taken into custody outside Drake's Bridle Path mansion Wednesday afternoon after he tried to gain access to the residence.
Canucks claw out 5-4 comeback win over Oilers in Game 1
Dakota Joshua had a goal and two assists and the Vancouver Canucks scored three third-period goals to claw out a 5-4 comeback victory over the Edmonton Oilers in Game 1 of their second-round playoff series Wednesday.
U.S. presidential candidate RFK Jr. had a brain worm, has recovered, campaign says
Independent U.S. presidential candidate Robert F. Kennedy Jr. had a parasite in his brain more than a decade ago, but has fully recovered, his campaign said, after the New York Times reported about the ailment.
Florida deputies who fatally shot U.S. airman burst into wrong apartment, attorney says
Deputies responding to a disturbance call at a Florida apartment complex burst into the wrong unit and fatally shot a Black U.S. Air Force airman who was home alone when they saw he was armed with a gun, an attorney for the man's family said Wednesday.
'A beautiful soul': Funeral held for baby boy killed in wrong-way crash on Highway 401
A funeral was held on Wednesday for a three-month-old boy who died after being involved in a wrong-way crash on Highway 401 in Whitby last week.
Nijjar murder suspect says he had Canadian study permit in immigration firm's video
One of the Indian nationals accused of murdering British Columbia Sikh activist Hardeep Singh Nijjar says in a social media video that he received a Canadian study permit with the help of an Indian immigration consultancy.
Pfizer agrees to settle more than 10K lawsuits over Zantac cancer risk: Bloomberg News
Pfizer has agreed to settle more than 10,000 lawsuits about cancer risks related to the now discontinued heartburn drug Zantac, Bloomberg News reported on Wednesday, citing people familiar with the deal.